الرئيسية › دليل الباحثين › Abderrahim Khélif
Abderrahim Khélif
الانتماء : Hôpital Farhat Hached · University of Sousse
- 97منشورات (انتماء تونسي)
- 129مجموع المنشورات
- 1575الاستشهادات
- 18مؤشر h
الملف البحثي
لدى Abderrahim Khélif 97 منشور(ات) مفهرسة (1993–2026). تُنشر أعماله أساسًا في «Blood»، «HemaSphere» و«Bulletin du Cancer». أكثر مقالاته استشهادًا هو «A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia» (2020)، وقد استُشهد به 332 مرة. 11 من هذه المنشورات تعود إلى آخر ثلاث سنوات من النشاط. شارك في تأليف أعماله 12 باحثًا على الأقل، منهم باحثون من مؤسسات في إيطاليا، فرنسا، الولايات المتحدة، العراق.
هل هذا أنت؟ عرّف بأبحاثك
أنشئ ملفك على DzCademia مجانًا وأضف مقالاتك: ستظهر بسهولة أكبر على Google وفي مساعدي الذكاء الاصطناعي مثل ChatGPT، فيقرؤها ويستشهد بها عدد أكبر من الناس.
إنشاء ملفي المجاني إضافة منشوراتيمجالات البحث
- Platelet Disorders and Treatments
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Viral-associated cancers and disorders
المنشورات (97)
- Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency
- Corrigendum to “Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency” [Thromb. Res. volume 259 (2026) https://doi.org/10.1016/j.thromres.2026.109616]
- Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia ( ADVANCE SC ): A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled, Phase 3 Trial
- Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial
- Pharmacokinetics, Hemostatic Efficacy, and Safety of a New Human Fibrinogen Concentrate in Adult and Pediatric Patients with Congenital Fibrinogen Deficiency
- 639 | DIFFUSE LARGE B CELL LYMPHOMA: A TUNISIAN MULTICENTER EXPERIENCE
- The prolong trial: A two Phase randomized placebo-controlled trial to optimize rituximab response with dexamethasone and maintenance therapy with low dose rituximab in immune thrombocytopenia (ITP) patients
- HTRS2025.P1.19 A New Fibrinogen Concentrate for Congenital Fibrinogen Deficiency: Pharmacokinetic Parameters and Efficacy
- Case Report: Acquired hemophilia A following COVID-19 vaccine
- Some Hematological Indices as Predictors of Survival in Chronic Myeloid Leukemia Patients
- Molecular characterization of Tunisian B-acute lymphoblastic leukemia
- Human herpesvirus-8 infection in Tunisian adult acute leukemia patients
- Acute Pancreatitis in Children with Acute Lymphoblastic Leukemia Using L-Asparaginase: A Review of the Literature
- Subsets of natural killer cells in chronic myeloid leukemia and their relation with some inflammatory cytokines
- A first Tunisian pilot study investigating sexual dysfunctions in patients with hemophilia.
- A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: case report and review of literature
- PB2262: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA
- PB2263: TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED/ REFRACTORY HODGKIN LYMPHOMA.
- PB1919: MATURE B-CELL NEOPLASMS CD5 NEGATIVE: CONFRONTATION CYTOMETRY-CYTOLOGY
- PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
- PB2560: LYSOSOMAL STORAGE DISEASES: GUACHER’S DISEASE AND NIEMANPICK ‘S DISEASES: STUDY OF CLINICAL, CYTOLOGICAL AND ENZYMATIC ASPECTS
- PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.
- PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE
- PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
- PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.
- Molecular characterization of a Tunisian B-lineage leukemia using Kde gene rearrangements
- Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies
- Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
- Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study
- Anémie hémolytique auto-immune du sujet âgé de plus de 75 ans : étude rétrospective de 24 patients
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
- Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy
- Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study
- Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia in the Believe Trial
- Sustained Reductions in Red Blood Cell (RBC) Transfusion Burden and Events in β-Thalassemia with Luspatercept: Longitudinal Results of the Believe Trial
- Invasive infection caused by Geotrichum capitatum in three patients with acute myeloid leukemia
- Presence of cytomegalovirus and human herpesvirus 6 in-patients with lymphomas
- Effects of Luspatercept on Iron Overload and Impact on Responders to Luspatercept: Results from the BELIEVE Trial
- The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials
- Evaluating Luspatercept Responders in the Phase 3, Randomized, Double-Blind, Placebo-Controlled BELIEVE Trial of Luspatercept in Adult Beta-Thalassemia Patients (Pts) Who Require Regular Red Blood Cell (RBC) Transfusions
- Prospective surveillance of hospital associated infections epidemiology in a haematology-oncology department
- REACH: A programme for improving care in haemophilia
- Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study
- Anémie hémolytique auto-immune (AHIA) du sujet âgé : étude rétrospective de 45 patients
- Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
- The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions
- Protocole national Tunisien prospectif de traitement du Lymphome de Hodgkin de l’adulte : résultats d’un schéma thérapeutique adapté à la réponse par tomodensitométrie à 2 cycles, à propos de 444 patients
- Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag (EPAG) in Patients Who Did and Did Not Receive Prior Rituximab (Ritux): A Post-Hoc Analysis of the Extend Study
- Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
- GATA2 gene analysis in several forms of hematological malignancies including familial aggregations
- Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements
- Fatal anaphylactic reaction to intravenous infusion of Ondansetron: a report of two cases
- Occurrence and Management of Cataracts in Adult Patients (pts) with Chronic Immune Thrombocytopenia (cITP) during Long-Term Treatment with Eltrombopag (EPAG): Results from the Extend Study
- Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases
- ARLTS1, potential candidate gene in familial aggregation of hematological malignancies
- Hepatobiliary and Thromboembolic Events during Long-Term E.X.T.E.N.Ded Treatment with Eltrombopag in Adult Patients with Chronic Immune Thrombocytopenia (ITP)
- Familial hematological malignancies: new IDH2 mutation
- Efficacy of Eltrombopag in Adult East Asian and Non-East Asian Patients with Chronic Immune Thrombocytopenia (cITP): Results from the Extend Study
- Improvements in Patient Health-Related Quality of Life (HRQoL) with Clinical Efficacy in Patients Treated with Eltrombopag: Final Results from the Long-Term, Open-Label Extend Study
- Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies
- Cytokine and cellular responses to human herpesvirus‐6B in patients with B‐acute lymphoblastic leukemia
- Patient-Reported Health-Related Quality of Life Improves over Time in Patients with Chronic Immune Thrombocytopenia Receiving Long-Term Treatment with Eltrombopag
- Combined IKZF1 and IG markers as new tools for diagnosis and minimal residual disease assessment in Tunisian B-ALL
- Synchronous Thyroid and Gastric Mantle Cell Lymphoma
- Successful Chemo-radiotherapy of Primary T- anaplastic Central Nervous Lymphoma: A Case Report
- Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use
- Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
- Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia)
- Familial hematological malignancies: ASXL1 gene investigation
- Microsatellite Typing of Aspergillus flavus Strains in a Tunisian Onco-hematology Unit
- Prospective, Multinational/Regional, Non-Interventional Study to Assess Treatment Practices in Anemia Patients Prone to Iron Overload: Results from the 3-Year Transfusional Hemosiderosis Registry (TORS)
- In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
- Characteristics of Invasive Aspergillosis in Neutropenic Haematology Patients (Sousse, Tunisia)
- Quantitative analysis of human herpesvirus‐6 and human cytomegalovirus in blood and saliva from patients with acute leukemia
- Association anémie hémolytique auto-immune et maladies auto-immunes
- Aspergillose cérébrale en hématologie : apport de l’imagerie. À propos de deux cas
- A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11)
- Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study – The Ritp Study (NCT00344149)
- Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia
- Contamination fongique de l’alimentation des patients d’onco-hématologie
- CD4+/CD56+ Hematodermic Neoplasm Presenting in the Skin: A Tunisian Case Report and Current Review of the Literature
- Aspects cliniques, biologiques, cytogénétiques et moléculaires de la leucémie myéloïde chronique chez le sujet âgé
- Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients
- Translocation t(X;10)(p10;p10): a rare chromosomal abnormality in a new born female with acute myeloid leukemia
- Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients
- Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report
- Xmn I polymorphism associated with concomitant activation of Gγ and Aγ globin gene transcription on a β0-thalassemia chromosome
- Leucémies aiguës myéloïdes en Tunisie: caractéristiques épidémiologiques et cliniques et classification OMS
- Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9
- Molecular study of CEPBA in familial hematological malignancies
- Evaluation of Hepatobiliary Parameters During Eltrombopag Treatment in Patients with Chronic Immune Thrombocytopenic Purpura.
- Etude du profil antigénique des blastes au cours des leucémies aiguës lymphoblastiques : analyse de 152 cas par cytométrie en flux
- A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34)
- Hodgkin Lymphoma (HL) in Tunisia Results of a 5 Year Prospective Multicenter Trial in 251 Pts
- Chemiluminescent detection of clonal immunoglobulin and T cell receptor gene rearrangements in Tunisian lymphoid malignancies, leukemias and lymphomas
- A nonsense mutation in the GPIIb heavy chain (Ser 870 → stop) impairs platelet GPIIb–IIIa expression
- TICLOPIDINE AND APLASTIC ANAEMIA
مجلات النشر
- Blood × 19
- HemaSphere × 9
- Bulletin du Cancer × 4
- British Journal of Haematology × 4
- La Revue de Médecine Interne × 4
- Medical Oncology × 4
المنشورات حسب السنة
- 20263
- 20255
- 20243
- 202314
- 20221
- 20214
- 20207
- 20197
- 20184
- 20175
التعاون العلمي
المؤسسات الشريكة : University of Milan · University of Campania "Luigi Vanvitelli" · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · Ente Ospedaliero Ospedali Galliera · Azienda Ospedaliera G. Brotzu
بلدان المؤلفين المشاركين : إيطاليا · فرنسا · الولايات المتحدة · العراق
المؤلفون المشاركون
- Yosra Ben Youssef
- Haifa Regaieg
- Kmira Zahra
- Monia Zaier
- Zohra Soua
- Nesrine Ben Sayed
- Béchir Achour
- Mohamed Adnène Laatiri
- Ayda Bennour
- Halima Sennana
- Walid Sabri Hamadou
- Moez Elloumi
البيانات البيبليوغرافية مصدرها OpenAlex (قاعدة مفتوحة).
لماذا تختارون Dzcademia؟
ملفات أكاديمية ومقالات ومداخلات علمية: امنحوا أبحاثكم حضوراً عاماً منظماً. تساعد البيانات الوصفية المدمجة محركات البحث ومساعدات الذكاء الاصطناعي على التعرف على أعمالكم وفهم مراجعها.
علّق عبر Google
سجّل الدخول عبر Google للتعليق مباشرة على هذه الصفحة.